EMA, new features for the PRIority Medicines (PRIME) scheme
By Giuliana Miglierini Based on the review of results obtained in the first five years of implementation of…
EMA’s Industry stakeholders group (ISG)
by Giuliana Miglierini The Industrial Stakeholder Group (ISG) is a new initiative recently launched by the European Medicines…
A new role for EMA and a pilot project for the repurposing of medicines
by Giuliana Miglierini A draft agreement was reached at the end of October between the Council of the…